Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer (PANDORA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01528683|
Recruitment Status : Completed
First Posted : February 8, 2012
Last Update Posted : May 17, 2018
University Hospital Heidelberg
Information provided by (Responsible Party):
Juergen Debus, University Hospital Heidelberg
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||May 2018|
|Actual Study Completion Date :||May 2018|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Habermehl D, Wagner M, Ellerbrock M, Büchler MW, Jäkel O, Debus J, Combs SE. Reirradiation Using Carbon Ions in Patients with Locally Recurrent Rectal Cancer at HIT: First Results. Ann Surg Oncol. 2015;22(6):2068-74. doi: 10.1245/s10434-014-4219-z. Epub 2014 Nov 11.
Combs SE, Kieser M, Habermehl D, Weitz J, Jäger D, Fossati P, Orrechia R, Engenhart-Cabillic R, Pötter R, Dosanjh M, Jäkel O, Büchler MW, Debus J. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial. BMC Cancer. 2012 Apr 3;12:137. doi: 10.1186/1471-2407-12-137.